NasdaqGS:TEMLife Sciences
Tempus AI (TEM) Unveils 100,000 Genome Platform Built For AI Healthcare
Tempus AI (NasdaqGS:TEM) announced a new whole-genome sequencing research platform designed for AI-driven healthcare insights.
The initiative aims to integrate more than 100,000 whole genomes with longitudinal clinical data in a model-ready environment.
The dataset is being built for computational use, targeting disease research and drug development collaborations with pharmaceutical and academic partners.
This launch of a multimodal whole-genome sequencing research platform comes against a...